Dr Valentina Puntmann
Consultant Cardiologist, MD, PhD, FRCP
Career at glance
|
Qualifications |
|
2019 CCST (Board Exam), Internal Medicine/Cardiology, Germany
2011 CCST (Board Exam), Internal Medicine/Clinical Pharmacology, United Kingdom 2006 MRCP (Royal College of Physicians UK) 2004 PhD (Doctor of Science); St. George’s/ University of Ljubjana, 2000 Medical Licence and Professional Registration, Slovenia 1999 MD (Doctor of Medicine), University Ljubljana, Slovenia |
Accreditations |
|
EuroCMR Recertification (2019)
EACVI TTE (2018) SCMR level III (2011) SCCT level II (2011) EuroCMR level III (2011) British Society of Echocardiography (2006) Advanced Life Support (2006, 2011, 2014, 2018) |
T1 mapping - a biomarker of diffuse myocardial disease T1 mapping by CMR is emerging as a quantifiable biomarker supporting the non-invasive characterisation of diffuse myocardial disease, which underscores the underlying pathophysiology of non-ischaemic cardiomyopathies. We undertook the International T1 Multicentre CMR Study, focusing on validation, standardization and translation of T1 mapping imaging for clinical use.
|
Myocarditis and inflammatory cardiomyopathiesMyocarditis is a major cause of cardiac morbidity and mortality and a condition with spectrum of challenges from establishing the diagnosis to effective treatment. Endomyo-cardial biopsy remains the diagnostic gold standard, despite its invasiveness, low diagnostic yield and a paucity of consequential management path-ways. CMR based on Lake Louise criteria partially provides a non-invasive diagnostic alternative allowing confirmation, but not exclusion of disease. T1 mapping now allows a high diagnostic accuracy in confirmation and exclusion of disease, staging and activity of disease.
|
Proof of concept drug studies (Phase II)Recent scientific advances have considerably improved our insight into the mecha-nisms and potential thera-peutic targets in myocarditis and inflammatory cardio-myopathies. Cardiac magnetic resonance based on T1 mapping and late gadolinium enhancement may support a modern diagnostic pathway identifying patients that might benefit from anti-inflammatory intervention.
|
Key publications
1. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 27:e203557.
2. Nagel E, Greenwood JP, McCann GP, Bettencourt N, Shah AM, Hussain ST, Perera D, Plein S, Bucciarelli-Ducci C, Paul M, Westwood MA, Marber M, Richter WS, Puntmann VO, Schwenke C, Schulz-Menger J, Das R, Wong J, Hausenloy DJ, Steen H, Berry C; MR-INFORM Investigators. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019 Jun 20;380(25):2418-2428.
3. Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, D'Cruz DP, Carr-White G, Marber M, Schnoes K, Arendt C, Klingel K, Vogl TJ, Zeiher AM, Nagel E, Puntmann VO. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018 Nov;77(11):1590-1598.
3. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Rolf A, Zitzmann S, Peker E, D'Angelo T, Pathan F, Elen, Valbuena S, Hinojar R, Arendt C, Narula J, Herrmann E, Zeiher AM, Nagel E; International T1 Multicentre CMR Outcome Study. Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2018 Feb 20;71(7):766-778.
4. Puntmann VO, Valbuena S, Hinojar R, Petersen SE, Greenwood JP, Kramer CM, Kwong RY, McCann GP, Berry C, Nagel E; SCMR Clinical Trial Writing Group. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018 Sep 20;20(1):67.
5. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R; Kelle S, Hinojar R, Doltra A, Varma N ,Child N; Rogers T; Arroyo Ucar E, Goodman B, Suna G; Khan S; Dabir D, Herrmann E, Zeiher AM, Nagel E. T1-mapping and outcome in nonischaemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovascular Imaging 2016;9(1):40-50.
6. Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. Radiology. 2017 Oct;285(1):63-72.
7. Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu CY, McCrohon J, Higgins DM, Carr-White G, Mayr M, Nagel E, Puntmann VO. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37-46.
8. Varma N, Hinojar R, D'Cruz D, Arroyo Ucar E, Indermuehle A, Peel S, Greil G, Gaddum N, Chowienczyk P, Nagel E, Botnar RM, Puntmann VO.Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients. JACC Cardiovasc Imaging. 2014 Aug;7(8):762-70
9. Puntmann VO, D'Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295-301.
10. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(4):475-84.
2. Nagel E, Greenwood JP, McCann GP, Bettencourt N, Shah AM, Hussain ST, Perera D, Plein S, Bucciarelli-Ducci C, Paul M, Westwood MA, Marber M, Richter WS, Puntmann VO, Schwenke C, Schulz-Menger J, Das R, Wong J, Hausenloy DJ, Steen H, Berry C; MR-INFORM Investigators. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019 Jun 20;380(25):2418-2428.
3. Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, D'Cruz DP, Carr-White G, Marber M, Schnoes K, Arendt C, Klingel K, Vogl TJ, Zeiher AM, Nagel E, Puntmann VO. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018 Nov;77(11):1590-1598.
3. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Rolf A, Zitzmann S, Peker E, D'Angelo T, Pathan F, Elen, Valbuena S, Hinojar R, Arendt C, Narula J, Herrmann E, Zeiher AM, Nagel E; International T1 Multicentre CMR Outcome Study. Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2018 Feb 20;71(7):766-778.
4. Puntmann VO, Valbuena S, Hinojar R, Petersen SE, Greenwood JP, Kramer CM, Kwong RY, McCann GP, Berry C, Nagel E; SCMR Clinical Trial Writing Group. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification. J Cardiovasc Magn Reson. 2018 Sep 20;20(1):67.
5. Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R; Kelle S, Hinojar R, Doltra A, Varma N ,Child N; Rogers T; Arroyo Ucar E, Goodman B, Suna G; Khan S; Dabir D, Herrmann E, Zeiher AM, Nagel E. T1-mapping and outcome in nonischaemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovascular Imaging 2016;9(1):40-50.
6. Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 Mapping in Recognition of Early Cardiac Involvement in Systemic Sarcoidosis. Radiology. 2017 Oct;285(1):63-72.
7. Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu CY, McCrohon J, Higgins DM, Carr-White G, Mayr M, Nagel E, Puntmann VO. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37-46.
8. Varma N, Hinojar R, D'Cruz D, Arroyo Ucar E, Indermuehle A, Peel S, Greil G, Gaddum N, Chowienczyk P, Nagel E, Botnar RM, Puntmann VO.Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients. JACC Cardiovasc Imaging. 2014 Aug;7(8):762-70
9. Puntmann VO, D'Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295-301.
10. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(4):475-84.
Patent of Invention
A method for differentiation of normal myocardium from diffuse disease using T1-mapping in nonischemic cardiomyopathies and others (based on PR-MS 33.297, PR-MS 33.837, PR-MS 33.654).
Private Consultations
Dr Puntmann offers clinical appointments upon request at her practices in London and Frankfurt. Dr Puntmann also offers virtual consultations, second opinions, outpatients cardiac investigations (Blood tests, ECG, Echocardiography, Treadmill testing), as well as directly supervises the Cardiac MRI scans. Please fill out the form and we will contact you as soon as possible.
London, United Kingdom |
Frankfurt am Main, Germany |
|
The Lister Hospital HCA, Chelsea Bridge Road, SW1W 8RH London
Chelsea Outpatient Centre HCA, 280 King's Rd, London SW3 5AW Chelsea EnquiriesEmail: drpuntmann@icloud.com
|
Kardiologische Privatpraxis Priv. Doz. Dr. Puntmann
Bockenheimer Landstraße 23, 60325 Frankfurt am Main |
